Opexa Therapeutics (OPXA) Board Approves One-for-Eight Reverse Stock Split
Tweet Send to a Friend
Opexa Therapeutics (Nasdaq: OPXA) announced that its Board of Directors approved a 1-for-8 reverse stock split of its common stock ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
